Protara Therapeutics (TARA) Goodwill (2020 - 2022)

Protara Therapeutics (TARA) has reported Goodwill for 3 consecutive years, with $29.5 million the latest figure, recorded in Q3 2022.

• In Q3 2022, Goodwill changed 0.0% year-over-year to $29.5 million; the TTM figure through Sep 2022 stood at $29.5 million (changed 0.0% YoY), while the FY2021 annual figure was $29.5 million, changed 0.0% from the prior year.
• Goodwill was little changed at $29.5 million in Q3 2022 per TARA's latest filing, from $29.5 million in the prior quarter.
• Across five years, Goodwill topped out at $29.5 million in Q4 2020 and bottomed at $29.4 million in Q1 2020.
• Historically, Goodwill has averaged $29.5 million across 3 years, with a median of $29.5 million in 2020.
• On a YoY basis, Goodwill climbed as much as 0.51% in 2021 and fell as far as 0.0% in 2021.
• Protara Therapeutics' Goodwill stood at $29.5 million in 2020, then changed by 0.0% to $29.5 million in 2021, then changed by 0.0% to $29.5 million in 2022.
• Business Quant data shows TARA's Goodwill at $29.5 million in Q3 2022, $29.5 million in Q2 2022, and $29.5 million in Q1 2022.